Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 7.32
+0.30 (4.27%)
Jan 23, 2026, 3:29 PM IST
Vivimed Labs Company Description
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India.
It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments.
It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
Vivimed Labs Limited
| Country | India |
| Founded | 1988 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 586 |
| CEO | Santosh Varalwar |
Contact Details
Address: 6-3-866/1/G 1, GMR Towers Hyderabad, 500016 India | |
| Phone | 91 40 6608 6608 |
| Website | vivimedlabs.com |
Stock Details
| Ticker Symbol | VIVIMEDLAB |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE526G01021 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Santosh Varalwar | MD and Executive Director |
| Ramakanta Tripathy | Chief Financial Officer |
| Yugandhar Kopparthi | Compliance Officer and Company Secretary |
| Dr. Manohar Rao Varalwar | Whole Time Director |
| Sandeep Varalwar B.Pharma | Executive Director |
| Mark I. Robbins | Chief Executive of Uquifa - Vivimed's API Division |